Abbott Laboratories
NYSE:ABT
Abbott Laboratories
PP&E Gross
Abbott Laboratories
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
PP&E Gross
$10.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Becton Dickinson and Co
NYSE:BDX
|
PP&E Gross
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
PP&E Gross
$3.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
PP&E Gross
$3.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dexcom Inc
NASDAQ:DXCM
|
PP&E Gross
$1.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's PP&E Gross?
PP&E Gross
10.2B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's PP&E Gross amounts to 10.2B USD.
What is Abbott Laboratories's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
5%
Over the last year, the PP&E Gross growth was 9%. The average annual PP&E Gross growth rates for Abbott Laboratories have been 5% over the past three years , 4% over the past five years , and 5% over the past ten years .